Stock APDN APPLIED DNA SCIENCES, INC.
Add to a list
To use this feature you must be a member
Log inSign up

News Applied DNA Sciences, Inc.

Equities

APDN

US03815U3005

Market Closed - Nasdaq
Other stock markets
 03:53:14 2024-04-16 pm EDT 		5-day change 1st Jan Change
0.3443 USD -4.41% Intraday chart for Applied DNA Sciences, Inc. -12.26% -44.18%
Apr. 03 Certain Warrants of Applied DNA Sciences, Inc. are subject to a Lock-Up Agreement Ending on 3-APR-2024. CI
Apr. 03 Certain Options of Applied DNA Sciences, Inc. are subject to a Lock-Up Agreement Ending on 3-APR-2024. CI

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Certain Warrants of Applied DNA Sciences, Inc. are subject to a Lock-Up Agreement Ending on 3-APR-2024.
CI
Certain Options of Applied DNA Sciences, Inc. are subject to a Lock-Up Agreement Ending on 3-APR-2024.
CI
Certain Common Stock of Applied DNA Sciences, Inc. are subject to a Lock-Up Agreement Ending on 3-APR-2024.
CI
Applied DNA to Showcase Linea DNA and Linea IVT Platforms at 24th Annual World Vaccine Congress
AQ
Applied DNA Sciences, Inc. to Showcase Linea DNA and Linea IVT Platforms At 24Th Annual World Vaccine Congress
CI
Applied DNA Sciences Files Prospectus for Potential Secondary Stock Offerings
MT
Applied DNA Sciences: Fiscal Q1 Earnings Snapshot
AQ
Transcript : Applied DNA Sciences, Inc., Q1 2024 Earnings Call, Feb 08, 2024
Earnings Flash (APDN) APPLIED DNA SCIENCES Reports Q1 Revenue $891,164
MT
Applied DNA Sciences, Inc. Reports Earnings Results for the First Quarter Ended December 31, 2023
CI
Applied DNA Announces $3.44 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules
AQ
Applied DNA Announces Joint Development Agreement to Integrate Linea IVT Platform into CDMO Kudo Biotechnology's mRNA Manufacturing Workflow
AQ
Applied DNA Sciences, Inc. Announces Joint Development Agreement to Integrate Linea IVT Platform into CDMO Kudo Biotechnology?s mRNA Manufacturing Workflow
CI
HC Wainwright Cuts Price Target on Applied DNA Sciences to $2 From $4, Keeps Buy Rating
MT
Applied DNA Sciences: Fiscal Q4 Earnings Snapshot
AQ
Transcript : Applied DNA Sciences, Inc., Q4 2023 Earnings Call, Dec 07, 2023
Earnings Flash (APDN) APPLIED DNA SCIENCES Posts Q4 Revenue $779,736, vs. Street Est of $1.7M
MT
Applied DNA Sciences, Inc. Reports Earnings Results for the Fourth Quarter Ended September 30, 2023
CI
Applied DNA Sciences, Inc. Reports Earnings Results for the Full Year Ended September 30, 2023
CI
Applied DNA to Report Fiscal 2023 Fourth Quarter and Year End Financial Results on December 7, 2023
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. APDN Stock
  4. News Applied DNA Sciences, Inc.